Daehan New Pharm Co. Ltd (054670) — Long-term Investment Intensity
Daehan New Pharm Co. Ltd (054670) has a Long-term Investment Intensity of 26.2% as of September 2018. Long-term investments of ₩30.87 Billion represent 26.2% of total assets of ₩117.93 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See what is Daehan New Pharm Co. Ltd's book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Daehan New Pharm Co. Ltd Long-term Investment Intensity (2014–2017)
This chart shows how Daehan New Pharm Co. Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2014 to 2017. As of September 2018, the intensity stands at 26.2%, reflecting long-term investments of ₩30.87 Billion against total assets of ₩117.93 Billion KRW. Also explore 054670 total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Daehan New Pharm Co. Ltd (2014–2017)
The table below presents the year-by-year Long-term Investment Intensity for Daehan New Pharm Co. Ltd from 2014 to 2017, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 054670 stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 27.2% | ₩33.09 Billion | ₩121.82 Billion | ▲ +1.2 pp |
| 2016 | 25.9% | ₩33.88 Billion | ₩130.72 Billion | ▼ -8.4 pp |
| 2015 | 34.3% | ₩45.53 Billion | ₩132.63 Billion | ▼ -0.8 pp |
| 2014 | 35.1% | ₩45.83 Billion | ₩130.47 Billion | — |